Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenical for Weight and Risk Factors in Lipid Clinic Patients
NCT00152360Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Jun 2005
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of orlistat in obesity, sponsored by University of British Columbia. Primary endpoint: Weight loss at 3 months. Started Jun 2005; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00152360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152360.